Skip to Content

Health

Pfizer vaccine provides less protection in cancer patients after a single dose, study finds

The Pfizer/BioNTech Covid-19 vaccine provides less protection in cancer patients than healthy individuals following a single dose, a new real-world study in the UK suggests, raising questions about whether the UK’s strategy to delay second doses should apply to such patients. A second dose of the vaccine at three weeks, however, boosted their protection significantly,

Continue Reading

Racial disparities in Covid-19 case rates among young people were prevalent early in the pandemic, CDC study says

Early in the pandemic, young people from all racial and ethnic minority groups had higher Covid-19 case rates than non-Hispanic White people under the age of 25, according to a study published Wednesday by the US Centers for Disease Control and Prevention. Between January and April, case rates compared to young White people were about

Continue Reading

US task force recommends lung cancer screening start earlier, include people with shorter histories of smoking

Annual lung cancer screening should include people as young as 50 and with shorter smoking histories, according to a new recommendation from an independent panel of experts that makes clinical recommendations to the American public. The US Preventive Services Task Force now recommends that current and former smokers ages 50 to 80, who have a

Continue Reading